血流储备分数与血管内超声指导PCI的比较
FLAVOUR试验随机分配1682例冠状动脉造影目测中等狭窄(40-70%)拟行PCI的患者,1:1接受FFR指导或IVUS指导的PCI决策与效果评估。FFR组PCI执行率44.4%,IVUS组65.3%。24个月主要复合终点(死亡、心肌梗死或血运重建)FFR组8.1% vs IVUS组8.5%,绝对差-0.4个百分点(单侧97.5%CI上限2.2个百分点),非劣效性P=0.01。西雅图心绞痛问卷患者报告结局两组相似。
要点
- 纳入标准为冠状动脉造影目测中等狭窄(40-70%闭塞)且拟行PCI评估的患者,随机分为FFR指导组与IVUS指导组(1:1)。
- FFR组PCI执行率为44.4%,IVUS组为65.3%,FFR指导显著减少了PCI实施。
- 24个月主要复合终点(死亡、心肌梗死或血运重建)FFR组8.1% vs IVUS组8.5%,绝对差-0.4个百分点(单侧97.5%CI上限2.2个百分点),非劣效性P=0.01。
- 两组西雅图心绞痛问卷患者报告结局相似。
适用人群与场景
- 因冠状动脉中等狭窄(冠状动脉造影目测40-70%闭塞)拟行PCI评估的患者。
诊断标准与关键阈值
- FFR组:FFR≤0.80时行PCI。
- IVUS组:最小管腔面积≤3 mm²,或最小管腔面积3-4 mm²且斑块负荷>70%时行PCI。
处置流程与药物剂量
- FFR指导组:依据FFR≤0.80决定是否行PCI,并用FFR评估PCI成功。
- IVUS指导组:依据最小管腔面积≤3 mm²或3-4 mm²伴斑块负荷>70%决定是否行PCI,并用IVUS评估PCI成功。
研究设计与关键结果
- 随机对照试验,纳入1682例冠状动脉造影目测中等狭窄(40-70%)拟行PCI患者,1:1随机分为FFR指导组与IVUS指导组。
- 主要终点为随机化后24个月死亡、心肌梗死或血运重建的复合终点。
- FFR组PCI执行率44.4%,IVUS组65.3%。
- 24个月主要复合终点事件FFR组8.1% vs IVUS组8.5%,绝对差-0.4个百分点(单侧97.5%CI上限2.2个百分点),非劣效性P=0.01。
- 西雅图心绞痛问卷患者报告结局两组相似。
证据类型、等级与局限
- 研究类型:随机对照试验(FLAVOUR,NCT02673424),由Boston Scientific资助。
- 非劣效性界值为2.5个百分点。
- 局限:原文未报告局限性
对床旁实践的改变
- 对于冠状动脉造影目测中等狭窄(40-70%)拟行PCI评估的患者,FFR指导与IVUS指导在24个月死亡、心肌梗死或血运重建复合终点上非劣效。
- FFR指导较IVUS指导减少PCI执行(44.4% vs 65.3%)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with coronary artery disease who are being evaluated for percutaneous coronary intervention (PCI), procedures can be guided by fractional flow reserve (FFR) or intravascular ultrasonography (IVUS) for decision making regarding revascularization and stent implantation. However, the differences in clinical outcomes when only one method is used for both purposes are unclear.
METHODS: We randomly assigned 1682 patients who were being evaluated for PCI for the treatment of intermediate stenosis (40 to 70% occlusion by visual estimation on coronary angiography) in a 1:1 ratio to undergo either an FFR-guided or IVUS-guided procedure. FFR or IVUS was to be used to determine whether to perform PCI and to assess PCI success. In the FFR group, PCI was to be performed if the FFR was 0.80 or less. In the IVUS group, the criteria for PCI were a minimal lumen area measuring either 3 mm2 or less or measuring 3 to 4 mm2 with a plaque burden of more than 70%. The primary outcome was a composite of death, myocardial infarction, or revascularization at 24 months after randomization. We tested the noninferiority of the FFR group as compared with the IVUS group (noninferiority margin, 2.5 percentage points).
RESULTS: The frequency of PCI was 44.4% among patients in the FFR group and 65.3% among those in the IVUS group. At 24 months, a primary-outcome event had occurred in 8.1% of the patients in the FFR group and in 8.5% of those in the IVUS group (absolute difference, -0.4 percentage points; upper boundary of the one-sided 97.5% confidence interval, 2.2 percentage points; P = 0.01 for noninferiority). Patient-reported outcomes as reported on the Seattle Angina Questionnaire were similar in the two groups.
CONCLUSIONS: In patients with intermediate stenosis who were being evaluated for PCI, FFR guidance was noninferior to IVUS guidance with respect to the composite primary outcome of death, myocardial infarction, or revascularization at 24 months. (Funded by Boston Scientific; FLAVOUR ClinicalTrials.gov number, NCT02673424.).
参考来源
- Koo BK, Hu X, Kang J, et al. Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI. N Engl J Med. 2022. PMID: 36053504. doi:10.1056/NEJMoa2201546
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。